Regulatory
Bad news for CBD: FDA objects to two NDI notifications for full-spectrum hemp ingredients
August 11th 2021Leading CBD companies Charlotte’s Web and Irwin Naturals submitted NDI notifications for full-spectrum hemp extracts. FDA objected to the notifications on the grounds of the drug-exclusion clause and the agency’s concern about safety substantiation.
NOW tests turmeric products sold on Amazon and finds potency, labeling, and other problems
August 11th 2021In June 2021, dietary supplements company NOW purchased from Amazon.com 23 non-NOW turmeric/curcumin supplement products, plus two of its own supplement products, and tested them for potency, heavy metals, labeling accuracy, and potential addition of synthetic curcumin.
Debate over mandatory product registry continues at 2021 Dietary Supplements Regulatory Summit
July 20th 2021During the 2021 Dietary Supplements Regulatory Summit, Cara Welch, PhD, acting director of FDA's Office of Dietary Supplement Programs, said that FDA was in favor of a mandatory product registry.